Related Experiment Video
Updated: May 23, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
IκB kinase regulation of the TPL-2/ERK MAPK pathway
Thorsten Gantke1, Srividya Sriskantharajah, Michael Sadowski
1Division of Immune Cell Biology, MRC National Institute for Medical Research, Mill Hill, London, UK.
Abstract:
Nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) activation play central roles in the induction of gene expression in innate immune cells following pathogen recognition. TPL-2 (tumor progression locus 2) is the MAP 3-kinase component of an ERK-1/2 (extracellular signal-regulated kinase 1/2) MAPK pathway activated by Toll-like receptor and tumor necrosis factor receptor family stimulation. In this review, we discuss results obtained from our laboratory and others that show that TPL-2 signaling function is directly controlled by the inhibitor of NF-κB (IκB) kinase (IKK) complex. Significantly, this means that IKK controls both NF-κB and ERK activation. TPL-2 is stoichiometrically complexed with the NF-κB inhibitory protein, NF-κB1 p105, and the ubiquitin-binding protein ABIN-2, both of which are required to maintain TPL-2 protein stability. Binding to p105 also prevents TPL-2 from phosphorylating MEK (MAPK/ERK kinase), its downstream target. Agonist stimulation releases TPL-2 from p105-inhibition by IKK-mediated phosphorylation of p105, which triggers degradation of p105 by the proteasome. This facilitates TPL-2 phosphorylation of MEK, in addition to liberating p105-associated Rel subunits to translocate into the nucleus. We also examine evidence that TPL-2 is critical for the induction of inflammation and may play a role in development and/or progression of certain types of cancer. Finally, we consider the potential of TPL-2 as an anti-inflammatory drug target for treatment of certain types of inflammatory disease and cancer.
Insights
The inhibitor of NF-κB (IκB) kinase (IKK) complex controls both NF-κB and ERK activation by regulating TPL-2 (tumor progression locus 2) signaling. This TPL-2 pathway is crucial for inflammation and cancer development.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways are central to innate immune responses.
- Toll-like receptor and tumor necrosis factor receptor family stimulation activate specific MAPK pathways, including the ERK-1/2 pathway involving TPL-2.
- The regulation of these critical signaling pathways is complex and not fully understood.
Purpose of the Study:
- To review the regulatory role of the IκB kinase (IKK) complex in TPL-2 signaling.
- To elucidate the mechanism by which IKK controls both NF-κB and ERK activation.
- To examine the role of TPL-2 in inflammation and cancer and its potential as a therapeutic target.
Main Methods:
- Review of existing laboratory data and published research.
- Analysis of protein-protein interactions and signaling cascades involving TPL-2, NF-κB1 p105, ABIN-2, and IKK.
- Examination of the functional consequences of TPL-2 pathway activation in cellular and disease models.
Main Results:
- TPL-2 signaling is directly controlled by the IKK complex, indicating IKK regulates both NF-κB and ERK activation.
- TPL-2 protein stability and activity are regulated by its complex with NF-κB1 p105 and ABIN-2.
- IKK-mediated phosphorylation of p105 releases TPL-2 inhibition, facilitating MEK phosphorylation and subsequent NF-κB nuclear translocation.
Conclusions:
- The IKK complex is a key regulator of TPL-2, linking innate immune receptor signaling to both NF-κB and ERK pathways.
- TPL-2 plays a critical role in inflammation and may contribute to cancer development and progression.
- TPL-2 represents a potential therapeutic target for inflammatory diseases and certain cancers.
Related Concept Videos
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of the Unfolded Protein Response
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

